Global Point of Care (POC) Urinalysis Market – Industry Trends and Forecast to 2030

Inhaltsverzeichnis anfordernInhaltsverzeichnis anfordern Mit Analyst sprechen Mit Analyst sprechen Jetzt kaufenJetzt kaufen Vor dem Kauf anfragen Vorher anfragen Kostenloser Beispielbericht Kostenloser Beispielbericht

Global Point of Care (POC) Urinalysis Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Reports
  • Dec 2022
  • Global
  • 350 Seiten
  • Anzahl der Tabellen: 220
  • Anzahl der Abbildungen: 60

Global Point Of Care Poc Urinalysis Market

Marktgröße in Milliarden USD

CAGR :  % Diagram

Diagramm Prognosezeitraum
2023 –2030
Diagramm Marktgröße (Basisjahr)
USD 19.18 Billion
Diagramm Marktgröße (Prognosejahr)
USD 53.35 Billion
Diagramm CAGR
%
Diagramm Wichtige Marktteilnehmer
  • Abbott
  • F. Hoffmann
  • La Roche Ltd
  • BD
  • Siemens Healthcare Private Limited

Global Point of Care (POC) Urinalysis Market, By Test Type (Pregnancy and Fertility Tests, Biochemical Urinalysis, Sediment Urinalysis), Application (Disease Screening, Pregnancy and Fertility), End User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, Research Laboratories and Institutes), Product (Consumables, Systems) – Industry Trends and Forecast to 2030.

Point of Care (POC) Urinalysis Market

Point of Care (POC) Urinalysis Market Analysis and Size

Major factors driving the growth of the market are the rising number of patients suffering from nephropathic disorders worldwide, the shift toward automation in sediment analysis, people's changing lifestyles, and the increasing prevalence of geriatric population are some of the major and impactful factors will likely boost the growth of the point of care (POC) urinalysis market during the forecast period of 2022-2030. On the other hand, increasing applications from emerging economies, as well as the adoption of integrated systems for urinalysis, will generate abundant opportunities, leading to the growth of the point of care (POC) urinalysis market during the forecast period.

Data Bridge Market Research analyses that the point of care (POC) urinalysis market which was USD 1.5 billion in 2022, is expected to reach USD 2.58 billion by 2030, at a CAGR of 7% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Point of Care (POC) Urinalysis Market Scope and Segmentation  

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Test Type (Pregnancy and Fertility Tests, Biochemical Urinalysis, Sediment Urinalysis), Application (Disease Screening, Pregnancy and Fertility), End User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, Research Laboratories and Institutes), Product (Consumables, Systems)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), BD (U.S.), Siemens Healthcare Private Limited (Germany), Bio-Rad Laboratories, Inc. (U.S.), Danaher (U.S), Sekisui Diagnostics (U.S.), Trinity Biotech (Ireland), bioMérieux (France), EKF Diagnostics (Germany), AccuBioTech Co., Ltd. (China), Instrumentation Laboratory (U.S.), Beckman Coulter, Inc. (U.S.), PTS Diagnostics (U.S.), Nova Biomedical (U.S.), Chembio Diagnostics, Inc. (U.S.), Quidel Corporation (U.S) and Sienco, Inc (U.S.)

Market Opportunities

  • Benefits related with OTC-based test

Market Definition

Global Point of Care (POC) Urinalysis Market Dynamics

Drivers

  • Increase in age-associated diseases

The ageing population in both developed and developing nations will benefit the market for urinalysis. The prevalence of age-related illnesses such diabetes, liver, and kidney disorders is anticipated to rise dramatically as the senior population overgrows in the forecast period. The growing number of prescriptions for tests like creatinine, albumin, glucose, ketones, and bilirubin among others is due to the diagnosis and treatment of such conditions. Since urinalysis is used to perform these tests, this market is anticipated to benefit.

  • Rising need for routine health check-ups

The market is growing as a result of the adaption of point-of-care diagnostics and the increased incidence of chronic diseases. Additionally, the desk-bound lifestyle of working people causes a general lack of good health among the populace in many areas, which promotes the demand for better diagnostics, including urinalysis. Therefore, the growing need for routine health checks is a key factor in the market's expansion.

Opportunities

  • Benefits related with OTC-based test

The point of care testing market for OTC tests is expected to develop at a 7.1% CAGR owing to an increase in OTC testing such as pregnancy tests and blood glucose tests that deliver results in a matter of seconds. These examinations do not necessitate the use of a skilled specialist and may be performed by individuals themselves, propelling the industry forward. For instance, The First Response kit is a rapid pregnancy test that gives you a result in 60 seconds. Accu-Chek active blood glucose meter kits also provide readings in 5 seconds, increasing market demand.

Restraints/Challenges

  • Unfavorable reimbursement scenario

The obtainability of refurbished instruments, which provide the same functions as new equipment at a reduced price, presents a threat to the expansion of this sector. Lack of solid regulatory frameworks could lead to an increase in the economy's consumption of second-hand goods.

  • High Cost

Factors affecting the urinalysis market from growing are the high equipment cost and stringent government regulations.

This point of care (POC) urinalysis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the point of care (POC) urinalysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Point of Care (POC) Urinalysis Market

The market will grow significantly in 2022 due to the increasing use of point-of-care tests that can quickly identify COVID-19. Because of the need for quick diagnostic results, point-of-care testing has become an important diagnostic technique. Because of the rapidly increasing number of COVID-19 cases and the growing pressure on governments to improve patient management, rapid antigen testing kits that can be used efficiently in point-of-care settings are in high demand. The rising prevalence of other respiratory disorders around the world, the shift toward decentralized diagnostics, and improved access to point-of-care devices via online platforms are all expected to fuel the market's long-term growth.

Global Point of Care (POC) Urinalysis Market Scope

The point of care (POC) urinalysis market is segmented on the basis of product, test type, application, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Test Type

  • Pregnancy and Fertility Tests
  • Biochemical Urinalysis
  • Laboratory tests
  • Point-of-care tests
  • Sediment Urinalysis

 Application

  • Disease Screening
  • Urinary tract infections
  • Kidney diseases
  • Diabetes
  • Liver diseases
  • Other disease screening applications
  • Pregnancy and Fertility

 End User

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Home Care Settings
  • Research Laboratories
  • Institutes

Product

  • Consumables
  • Systems

Point of Care (POC) Urinalysis Market Regional Analysis/Insights

The point of care (POC) urinalysis market is analyzed and market size insights and trends are provided by country, product, test type, application, and end user as referenced above.

The countries covered in the point of care (POC) urinalysis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the point of care (POC) urinalysis market due to the growing incidences of nephropathic disorders, the increasing number of healthcare infrastructure, and the prevalence of various manufacturers in the region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the growing demand of advanced urine analyzers along with occurrence of large patient population.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The point of care (POC) urinalysis market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for point of care (POC) urinalysis market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the point of care (POC) urinalysis market. The data is available for historic period 2011-2021.

Competitive Landscape and Point of Care (POC) Urinalysis Market Share Analysis

The point of care (POC) urinalysis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to point of care (POC) urinalysis market.

Some of the major players operating in the point of care (POC) urinalysis market are:

  • Abbott (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • BD (U.S.)
  • Siemens Healthcare Private Limited (Germany)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Danaher (U.S)
  • Sekisui Diagnostics (U.S.)
  • Trinity Biotech (Ireland)
  • bioMérieux (France)
  • EKF Diagnostics (Germany)
  • AccuBioTech Co., Ltd. (China)
  • Instrumentation Laboratory (U.S.)
  • Beckman Coulter, Inc. (U.S.)
  • PTS Diagnostics (U.S.)
  • Nova Biomedical (U.S.)
  • Chembio Diagnostics, Inc. (U.S.)
  • Quidel Corporation (U.S)
  • Sienco, Inc (U.S.)


SKU-

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

  • Interaktives Datenanalyse-Dashboard
  • Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
  • Zugriff für Research-Analysten für Anpassungen und Abfragen
  • Konkurrenzanalyse mit interaktivem Dashboard
  • Aktuelle Nachrichten, Updates und Trendanalyse
  • Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Demo anfordern

Forschungsmethodik

Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.

Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

Häufig gestellte Fragen

The market is segmented based on Global Point of Care (POC) Urinalysis Market, By Test Type (Pregnancy and Fertility Tests, Biochemical Urinalysis, Sediment Urinalysis), Application (Disease Screening, Pregnancy and Fertility), End User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, Research Laboratories and Institutes), Product (Consumables, Systems) – Industry Trends and Forecast to 2030. .
The Global Point Of Care Poc Urinalysis Market size was valued at USD 19.18 USD Billion in 2022.
The Global Point Of Care Poc Urinalysis Market is projected to grow at a CAGR of 7% during the forecast period of 2023 to 2030.
The major players operating in the market include Abbott, F. Hoffmann, La Roche Ltd, BD, Siemens Healthcare Private Limited, BioRad Laboratories, Danaher, Sekisui Diagnostics, Trinity Biotech, bioMérieux, EKF Diagnostics, AccuBioTech Co., Instrumentation Laboratory, Beckman Coulter, PTS Diagnostics, Nova Biomedical, Chembio Diagnostics, Quidel Corporation, Sienco, .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.